Jason X-J Yuan Selected Research

Inflammation (Inflammations)

2/2013	Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding.
6/2009	Inflammation, growth factors, and pulmonary vascular remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason X-J Yuan Research Topics

Disease

54	Pulmonary Hypertension 05/2024 - 02/2003
39	Hypoxia (Hypoxemia) 01/2023 - 12/2003
28	Pulmonary Arterial Hypertension 05/2024 - 09/2002
25	Vascular Remodeling 01/2023 - 09/2002
14	Familial Primary Pulmonary Hypertension 01/2021 - 09/2004
8	Right Ventricular Hypertrophy 01/2023 - 10/2010
6	Vascular Diseases (Vascular Disease) 01/2022 - 01/2011
5	Fibrosis (Cirrhosis) 01/2023 - 05/2011
4	Lung Injury 01/2021 - 10/2011
4	Neoplasms (Cancer) 01/2019 - 08/2011
4	Hypertrophy 01/2016 - 12/2005
3	Lung Diseases (Lung Disease) 11/2022 - 08/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2022 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2020
3	COVID-19 12/2020 - 01/2020
3	Hypertension (High Blood Pressure) 01/2014 - 12/2008
2	Hyperglycemia 05/2023 - 07/2008
2	Wounds and Injuries (Trauma) 05/2022 - 04/2006
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 02/2011
2	Starvation 01/2021 - 12/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2017
2	Critical Illness (Critically Ill) 01/2021 - 01/2017
2	Ventilator-Induced Lung Injury 01/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2013
2	Acute Lung Injury 01/2017 - 10/2011
2	Inflammation (Inflammations) 02/2013 - 06/2009
2	Lewy Body Disease (Lewy Body Dementia) 09/2008 - 04/2007
2	Cystic Fibrosis (Mucoviscidosis) 08/2007 - 01/2005
1	Hyperplasia 11/2022

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2003
12	MonocrotalineIBA 01/2023 - 10/2010
10	Ion Channels (Ion Channel)IBA 01/2023 - 09/2002
8	Messenger RNA (mRNA)IBA 01/2018 - 02/2003
5	Semaxinib (SU5416)IBA 01/2023 - 01/2019
5	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2013
5	Protein Isoforms (Isoforms)IBA 01/2015 - 01/2007
4	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 04/2024 - 02/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 06/2012
4	CalciumIBA 01/2022 - 01/2016
4	LigandsIBA 01/2022 - 05/2014
4	Therapeutic UsesIBA 01/2022 - 01/2017
4	CationsIBA 01/2022 - 01/2011
4	TRPC6 Cation ChannelIBA 12/2021 - 05/2009
4	Platelet-Derived Growth FactorIBA 07/2020 - 01/2012
4	Transient Receptor Potential ChannelsIBA 01/2019 - 09/2004
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2020 - 10/2008
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2011
3	Oxygen (Dioxygen)IBA 01/2020 - 10/2007
3	Calcium-Sensing ReceptorsIBA 01/2020 - 01/2013
3	CollagenIBA 01/2020 - 05/2011
3	N- (2- hydroxy- 3- (2- cyano- 3- chlorophenoxy)propyl)- 1,1- dimethyl- 2- (2- nephthyl)ethylamineIBA 02/2014 - 08/2012
3	Calcium Channels (Calcium Channel)IBA 07/2013 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2024 - 01/2020
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2023 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2016
2	CytokinesIBA 01/2022 - 06/2009
2	Thymidine Monophosphate (TMP)IBA 03/2021 - 01/2020
2	tetramethylpyrazineIBA 03/2021 - 01/2020
2	PotassiumIBA 01/2021 - 01/2005
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 10/2009
2	Conditioned Culture MediaIBA 07/2020 - 12/2005
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 12/2018
2	Stromal Interaction Molecule 2IBA 01/2020 - 01/2018
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2020 - 01/2017
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2020 - 12/2016
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 11/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 04/2014
2	TOR Serine-Threonine KinasesIBA 12/2018 - 01/2015
2	EnzymesIBA 01/2018 - 01/2014
2	Ether (Diethyl Ether)IBA 03/2016 - 01/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2015 - 10/2007
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2015 - 11/2009
2	Thrombin FDA Link 12/2013 - 12/2008
2	Angiopoietin-1IBA 10/2011 - 02/2003
2	Atrial Natriuretic Factor (ANF)IBA 05/2011 - 12/2005
2	Simvastatin (Zocor)FDA LinkGeneric 01/2011 - 10/2010
2	Sildenafil Citrate (Viagra)FDA Link 01/2011 - 10/2010
2	Caveolin 1IBA 07/2009 - 09/2007
2	alpha-SynucleinIBA 09/2008 - 04/2007
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 08/2007 - 01/2005
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2007 - 01/2005
2	Cyclic NucleotidesIBA 05/2007 - 01/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2024
1	Deubiquitinating EnzymesIBA 05/2024
1	UbiquitinIBA 05/2024
1	anacardic acidIBA 01/2024
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 01/2024
1	OxysterolsIBA 01/2024
1	1- (2- (2- ((7- chloroquinolin- 4- yl)amino)ethyl- methylamino)ethylamino)- 4- methylthioxanthen- 9- oneIBA 01/2023
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 11/2022
1	Calcitonin Gene-Related PeptideIBA 11/2022
1	NeuropeptidesIBA 11/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2022

Therapy/Procedure

10	Therapeutics 10/2022 - 04/2006
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2017